
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.120 | 7.120 | 0.000 |
Shares | 93.960 | 93.960 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.817 | 25.621 |
Price to Book | 1.773 | 2.911 |
Price to Sales | 4.692 | 3.839 |
Price to Cash Flow | 25.185 | 17.269 |
Dividend Yield | 1.112 | 1.870 |
5 Years Earnings Growth | 4.951 | 5.563 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 90.780 | 95.762 |
Basic Materials | 8.990 | 0.926 |
Industrials | 0.120 | 0.510 |
Technology | 0.080 | 0.701 |
Consumer Cyclical | 0.030 | 0.847 |
Consumer Defensive | 0.010 | 3.471 |
Number of long holdings: 80
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Hangzhou Tigermed Consulting | CNE100001KV8 | 4.69 | 52.10 | +4.14% | |
WuXi AppTec | CNE1000031K4 | 4.45 | 64.80 | +1.25% | |
Shanghai Haoyuan Chemexpress Co | CNE1000051J4 | 4.26 | 46.18 | +0.04% | |
Acrobiosystems | CNE100004S13 | 4.24 | 55.20 | +2.79% | |
Asymchem Laboratories Tian Jin | CNE100002BZ6 | 4.23 | 93.49 | +3.16% | |
Pharmaron Beijing | CNE100003JW4 | 4.16 | 24.51 | +2.98% | |
PharmaBlock Sciences A | CNE1000035K5 | 4.08 | 36.28 | +3.22% | |
MGI Tech | CNE100005PC8 | 4.02 | 69.36 | -1.03% | |
Suzhou Highfine Biotech | CNE1000064T6 | 3.99 | 58.11 | +9.89% | |
R G PharmaStudies | CNE100005K44 | 3.99 | 51.29 | +2.83% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongjia XinXiang Alloc A | 53.59M | 0.94 | 1.82 | - | ||
Zhongjia XinXiang Alloc C | 53.59M | 0.89 | 1.71 | - | ||
Zhongjia Reform Div Alloc Fd | 40.38M | 1.71 | -10.35 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review